Seasonality trends indicate the bms stock price forecast may benefit from the typical Q3 biotech rally pattern. Historical data points to average gains of 4.5% during similar market conditions over the past decade. NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures. While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number. Quantitative indicators suggest bms stock price forecast has a probability-weighted mean target near $59 by quarter-end, based on regression models factoring in interest rates, sector rotation, and earnings beats.
